Trial Profile
Study of asfotase alfa in adult patients with severe hypophosphatasia.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2015
Price :
$35
*
At a glance
- Drugs Asfotase alfa (Primary)
- Indications Hypophosphatasia
- Focus Therapeutic Use
- Sponsors Alexion AstraZeneca Rare Disease
- 02 Feb 2015 New trial record